Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population‐Based Study
Cancer Medicine · 2026
DOI: 10.1002/cam4.71558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Qian Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Carcinoma, Intraductal, Noninfiltrating, Breast Neoplasms, Neoplasm Recurrence, Local. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Auckland Research Development Fund, Auckland Medical Research Foundation.
Abstract (Originalsprache)
Background
Despite favourable survival prognosis, the main concern for ductal carcinoma in situ (DCIS) is local recurrence, especially progression to invasive cancer. This study identified factors associated with breast events following DCIS treatment.
Methods
Women with unilateral DCIS between 2000 and 2022 were identified from New Zealand Breast Cancer Foundation National Register. The primary endpoint was cumulative incidence of invasive breast cancer, ipsilateral (iIBC) or contralateral (iCBC). Secondary endpoints included ipsilateral breast event (IBE), in situ or invasive, and any breast event (IBE or CBC). Fine‐Gray models were used to identify the associated factors and estimate subdistribution hazard ratios (sHRs).
Results
Among 5740 patients followed for a median duration of 4.8 years, the 5‐ and 10‐year cumulative risks were 3.0% (95% CI, 2.4%, 3.5%) and 6.6% (95% CI, 5.7%, 7.6%) for iIBC, and 2.7% (95% CI, 2.2%, 3.3%) and 6.3% (95% CI, 5.4%, 7.3%) for iCBC, respectively. A higher risk of iIBC was observed in women aged under 45 at diagnosis (sHR, 1.81; 95% CI: 1.18, 2.79) or had DCIS size > 20 mm (sHR, 1.42; 1.05, 1.93), and a lower risk in those who received additional RT after BCS (HR: 0.61; 0.44, 0.84) or mastectomy (sHR, 0.21; 0.13, 0.32). Similar associations were observed for IBE and any breast event, for which surgical margin < 2 mm was also associated with a higher risk. Having surgery at a private facility, where higher‐risk patients were likely to be treated, was associated with a higher risk of iCBC.
Conclusions
DCIS size, surgical approach, and age at diagnosis influenced the risk of breast events after DCIS, which may be considered in efforts to improve treatment strategies for higher‐risk women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Cancer Epidemiology Unit, Oxford Population Health, University of Oxford, Oxford, UK.
ORCID-Profile: Qian Chen, Phyu Sin Aye
Förderung
- University of Auckland Research Development Fund
- Auckland Medical Research Foundation
Zitieren
APA
Chen, Q., Campbell, I., Elwood, M., Cavadino, A., Aye, P. S., & Tin Tin, S. (2026). Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population‐Based Study. Cancer Medicine. https://doi.org/10.1002/cam4.71558
Vancouver
Chen Q, Campbell I, Elwood M, Cavadino A, Aye PS, Tin Tin S. Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population‐Based Study. Cancer Medicine. 2026. doi:10.1002/cam4.71558
BibTeX
@article{Chen2026,
author = {Chen, Qian and Campbell, Ian and Elwood, Mark and Cavadino, Alana and Aye, Phyu Sin and Tin Tin, Sandar},
title = {Breast Events After Treatment of Ductal Carcinoma In Situ in Women: A Population‐Based Study},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71558}
}
EUVIMED